The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Hallmarks of cancer stem cell metabolism
Open accessAbstract
Cancer cells adapt cellular metabolism to cope with their high proliferation rate. Instead of primarily using oxidative phosphorylation (OXPHOS), cancer cells use less efficient glycolysis for the production of ATP and building blocks (Warburg effect). However, tumours are not uniform, but rather functionally heterogeneous and harbour a subset of cancer cells with stemness features. Such cancer cells have the ability to repopulate the entire tumour and thus have been termed cancer stem cells (CSCs) or tumour-initiating cells (TICs). As opposed to differentiated bulk tumour cells relying on glycolysis, CSCs show a distinct metabolic phenotype that, depending on the cancer type, can be highly glycolytic or OXPHOS dependent. In either case, mitochondrial function is critical and takes centre stage in CSC functionality. Remaining controversies in this young and emerging research field may be related to CSC isolation techniques and/or the use of less suitable model systems. Still, the apparent dependence of CSCs on mitochondrial function, regardless of their primary metabolic phenotype, represents a previously unrecognised Achilles heel amendable for therapeutic intervention. Elimination of highly chemoresistant CSCs as the root of many cancers via inhibition of mitochondrial function bears the potential to prevent relapse from disease and thus improve patients' long-term outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Self-citationAssociation of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 818
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. M., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 804
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer
Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., Schafer, Z. T., Evans, R. M., Suda, T., Lee, C.-H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2882 · Cited by 729
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722
Self-citationSamudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Škrtić, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.015 · Cited by 678
Metabolic Plasticity in Stem Cell Homeostasis and Differentiation
Folmes, C. D. L., Dzeja, P. P., Nelson, T. J., & Terzic, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.002 · Cited by 669
Targeting lipophilic cations to mitochondria
Murphy, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.029 · Cited by 598
Shackelford, D. B., Abt, E., Gerken, L., Vasquez, D. S., Seki, A., Leblanc, M., Wei, L., Fishbein, M. C., Czernin, J., Mischel, P. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.008 · Cited by 585
Mitochondria as signaling organelles
Chandel, N. S. (2014) · BMC Biology · doi:10.1186/1741-7007-12-34 · Cited by 576
Lamb, R., Ozsvari, B., Lisanti, C. L., Tanowitz, H. B., Howell, A., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3174 · Cited by 478
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Janiszewska, M., Suvà, M. L., Riggi, N., Houtkooper, R. H., Auwerx, J., Clément-Schatlo, V., Radovanovic, I., Rheinbay, E., Provero, P., & Stamenkovic, I. (2012) · Genes & Development · doi:10.1101/gad.188292.112 · Cited by 452
Lonardo, E., Hermann, P. C., Mueller, M.-T., Huber, S., Balic, A., Miranda-Lorenzo, I., Zagorac, S., Alcala, S., Rodriguez-Arabaolaza, I., Ramirez, J. C., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.001 · Cited by 405
Self-citationKordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J., & Wilmink, J. W. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00027-3 · Cited by 361
Martinez-Outschoorn, U. E., Prisco, M., Ertel, A., Tsirigos, A., Lin, Z., Pavlides, S., Wang, C., Flomenberg, N., Knudsen, E. S., Howell, A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15330 · Cited by 338
Pastò, A., Bellio, C., Pilotto, G., Ciminale, V., Silic-Benussi, M., Guzzo, G., Rasola, A., Frasson, C., Nardo, G., Zulato, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2010 · Cited by 293
A metabolic prosurvival role for PML in breast cancer
Carracedo, A., Weiss, D., Leliaert, A. K., Bhasin, M., de Boer, V. C. J., Laurent, G., Adams, A. C., Sundvall, M., Song, S. J., Ito, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62129 · Cited by 269
De Luca, A., Fiorillo, M., Peiris-Pagès, M., Ozsvari, B., Smith, D. L., Sanchez-Alvarez, R., Martinez-Outschoorn, U. E., Cappello, A. R., Pezzi, V., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4401 · Cited by 259
Mitochondrial and energy metabolism‐related properties as novel indicators of lung cancer stem cells
Ye, X., Li, Q., Wang, G., Sun, F., Huang, G., Bian, X., Yu, S., & Qian, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.25944 · Cited by 251
Intracellular autofluorescence: a biomarker for epithelial cancer stem cells
Miranda-Lorenzo, I., Dorado, J., Lonardo, E., Alcala, S., Serrano, A. G., Clausell-Tormos, J., Cioffi, M., Megias, D., Zagorac, S., Balic, A., et al. (2014) · Nature Methods · doi:10.1038/nmeth.3112 · Cited by 207
Self-citationMetabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
Shen, Y.-A., Wang, C.-Y., Hsieh, Y.-T., Chen, Y.-J., & Wei, Y.-H. (2015) · Cell Cycle · doi:10.4161/15384101.2014.974419 · Cited by 207
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13131 · Cited by 205
Farnie, G., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5401 · Cited by 205
Targeted Delivery of Doxorubicin to Mitochondria
Chamberlain, G. R., Tulumello, D. V., & Kelley, S. O. (2013) · ACS Chemical Biology · doi:10.1021/cb400095v · Cited by 198
Lamb, R., Harrison, H., Hulit, J., Smith, D. L., Lisanti, M. P., & Sotgia, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2789 · Cited by 190
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant
Chandel, N. S., Avizonis, D., Reczek, C. R., Weinberg, S. E., Menz, S., Neuhaus, R., Christian, S., Haegebarth, A., Algire, C., & Pollak, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.010 · Cited by 176 · cited 2×
“…Journal of Cancer (2016) 114, 1305–1312 | doi: 10.1038/bjc.2016.152 www.bjcancer.com | DOI:10.1038/bjc.2016.152 1305 Second, cancer heterogeneity also exists within each of these subclones, despite their identical genetic background, via the acquisition of stemness features in a subset of cells.”
BackgroundInfluentialMetabolic symbiosis in cancer: Refocusing the Warburg lens
Nakajima, E. C., & Van Houten, B. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21863 · Cited by 176
ISG15 Is a Critical Microenvironmental Factor for Pancreatic Cancer Stem Cells
Sainz, B., Martín, B., Tatari, M., Heeschen, C., & Guerra, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1354 · Cited by 166
Self-citationSáinz, B., Alcalá, S., García, E., Sanchez-Ripoll, Y., Azevedo, M. M., Cioffi, M., Tatari, M. N., Miranda‐Lorenzo, I., Hidalgo, M. M., Goméz-López, G., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308935 · Cited by 146
Self-citationLamb, R., Bonuccelli, G., Ózsvári, B., Peiris‐Pagès, M., Fiorillo, M., Smith, D. L., Bevilacqua, G., Mazzanti, C. M., McDonnell, L. A., Naccarato, A. G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5852 · Cited by 146
Senkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M. G., Nygren, P., Linder, S. T., Larsson, R. L., & Fryknäs, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0792 · Cited by 145
Cheng, G., Zielonka, J., McAllister, D. M., Mackinnon, A. C., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-285 · Cited by 135
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Wang, Y.-C., Chao, T., Chang, C., Yo, Y.-T., Yu, M.-H., & Lai, H.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074538 · Cited by 132
Growth Inhibition of Ovarian Tumor–Initiating Cells by Niclosamide
Yo, Y.-T., Lin, Y.-W., Wang, Y.-C., Balch, C., Huang, R., Chan, M. W. Y., Sytwu, H., Chen, C.-K., Chang, C., Nephew, K. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0002 · Cited by 122
Lamb, R., Fiorillo, M., Chadwick, A. L., Ózsvári, B., Reeves, K. J., Smith, D. L., Clarke, R. B., Howell, S. J., Cappello, A. R., Martinez‐Outschoorn, U., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4159 · Cited by 119
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
Dowling, R. J. O., Lam, S. H. L., Bassi, C., Mouaaz, S., Aman, A. M., Kiyota, T., Al‐awar, R., Goodwin, P. J., & Stambolic, V. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.006 · Cited by 119
Control of Tumor Bioenergetics and Survival Stress Signaling by Mitochondrial HSP90s
Chae, Y. C., Caino, M. C., Lisanti, S., Ghosh, J. C., Dohi, T., Danial, N. N., Villanueva, J., Ferrero, S., Vaira, V., Santambrogio, L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.015 · Cited by 117
Circulating cancer stem cells: the importance to select.
Yang, M.-H., Imrali, A., & Heeschen, C. (2015) · PubMed · doi:10.3978/j.issn.1000-9604.2015.04.08 · Cited by 104
Self-citationShen, Y., Lin, C., Chi, W.-H., Wang, C.-Y., Hsieh, Y.-T., Wei, Y., & Chen, Y.-J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/590393 · Cited by 103
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
Sivalingam, V. N., Kitson, S., McVey, R. J., Roberts, C., Pemberton, P. W., Gilmour, K., Ali, S., Renehan, A. G., Kitchener, H. C., & Crosbie, E. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.453 · Cited by 83
Circulating cancer stem cells: the importance to select
Ming-Hsin, Yang, Y., Ahmet, A., Imrali, Christopher, C., & Heeschen, C. (2015) · Chinese Journal of Cancer Research · Cited by 82
Self-citationOvarian tumor-initiating cells display a flexible metabolism
Anderson, A. S., Roberts, P. C., Frisard, M. I., Hulver, M. W., & Schmelz, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.028 · Cited by 73
Folmes, C. D. L., Martinez‐Fernandez, A., Faustino, R. S., Yamada, S., Pérez-Terzic, C. M., Nelson, T. J., & Terzic, A. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9431-2 · Cited by 57
Stem cells & pancreatic cancer
García-Silva, S., Frias-Aldeguer, J., & Heeschen, C. (2013) · Pancreatology · doi:10.1016/j.pan.2012.12.003 · Cited by 13
Self-citationClausell-Tormos, J. (2014) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000191 · Cited by 3
Cited by
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Targeting ROS in cancer: rationale and strategies
Glorieux, C., Liu, S., Trachootham, D., & Huang, P. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00979-4 · Cited by 651
Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 578
Metadata
- Authors
- Sancho, P., Barneda, D., & Heeschen, C.
- Venue
- British Journal of Cancer
- Published
- 2016-05-24
- Volume
- 114
- Issue
- 12
- Pages
- 1305-1312
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2396911170
- Cited by
- 574
- References
- 58
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.